Revenue (Quarterly) Chart

View Revenue (Quarterly) for ECGI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2005. Start Trial.
Date Value
May 31, 2026 0.119M
February 28, 2026 0.0625M
November 30, 2025 0.00
August 31, 2025 0.00
May 31, 2025 0.0009M
February 28, 2025 0.0007M
November 30, 2024 0.002M
August 31, 2024 0.00
May 31, 2024 0.0027M
February 29, 2024 0.00
November 30, 2023 0.00
August 31, 2023 0.00
May 31, 2023 0.00
February 28, 2023 0.00
November 30, 2022 0.00
August 31, 2022 0.00
May 31, 2022 0.00
February 28, 2022 0.00
November 30, 2021 0.00
August 31, 2021 0.00
May 31, 2021 0.00
February 28, 2021 0.00
November 30, 2020 0.00
August 31, 2020 0.00
May 31, 2020 0.00
Date Value
February 29, 2020 0.00
November 30, 2019 0.00
August 31, 2019 0.00
May 31, 2019 0.00
February 28, 2019 0.00
November 30, 2018 0.00
May 31, 2016 0.00
February 29, 2016 0.00
November 30, 2015 0.00
August 31, 2015 0.00
May 31, 2015 0.00
February 28, 2015 0.00
November 30, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.00
September 30, 2013 0.00
June 30, 2013 0.00
March 31, 2013 0.00
December 31, 2012 0.00
September 30, 2012 0.00
June 30, 2012 0.00
March 31, 2012 0.00
December 31, 2011 0.00

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Omnicell, Inc. 312.21M
Vaso Corp. 11.19M
Global Innovative Platforms, Inc. 0.0507M
Co-Diagnostics, Inc. 0.1661M
Spectral AI, Inc. 3.524M